Specifically, high CELF2 expression was dramatically associated with prolonged OS and RFS in breast cancer patients with ER negative, PR negative, HER2 negative, lymph node positive and grade 3 (OS and RFS: HR <1 and p < 0.05). This evidence concerns the gene CELF2 and breast cancer.